PedAM
Pediatric Disease Annotations & Medicines
| Disease | graft-vs-host disease |
| Phenotype | C0023418|leukemia |
| Sentences | 12 |
| PubMedID- 26011372 | Ofatumumab in a chronic lymphocytic leukemia patient with graft versus host disease and relapse after mini-allo bmt. |
| PubMedID- 25778912 | Mismatched hematopoietic cell transplants for treating leukemia are complicated by graft versus host disease (gvhd). |
| PubMedID- 22532520 | In vivo, the combination reduced the risk of graft-versus-host disease without hampering graft-versus-leukemia effect, as shown in mice receiving graft-versus-host disease prophylaxis with sirolimus plus bortezomib being infused with tumor wehi cells plus c57bl/6 donor bm and splenocytes. |
| PubMedID- 26445106 | Unrelated cord blood transplantation for adult patients with acute myeloid leukemia: higher incidence of acute graft-versus-host disease and lower survival in male patients transplanted with female unrelated cord blood--a report from eurocord, the acute leukemia working party, and the cord blood committee of the cellular therapy and immunobiology working party of the european group for blood and marrow transplantation. |
| PubMedID- 24410134 | Distribution and clonality of the valpha and vbeta t-cell receptor repertoire of regulatory t cells in leukemia patients with and without graft versus host disease. |
| PubMedID- 21122312 | [clinical study on the relapsd leukemia patients with graft versus host disease after allogeneic hematopoietic stem cell transplantation.] |
| PubMedID- 26039207 | Recent trials indicate that high doses of cd34+ progenitors from g-csf mobilized peripheral blood leukocytes isolated and t-cell depleted by immunoadsorption to paramagnetic beads, when administered after myeloablative conditioning with tbi and chemotherapy or chemotherapy alone can secure consistent engraftment and abrogate gvhd in patients with acute leukemia without incurring an increased risk of a recurrent leukemia. |
| PubMedID- 26190426 | Chronic gvhd is associated with a graft-versus-leukemia effect (gvl) resulting in a decreased incidence of relapse.13 in this study, the incidence was 9.2% versus 25.0% as reported by zecca et al.13 however in this study the follow-up was only up to 180 days after transplant. |
| PubMedID- 25363669 | Il-35 mitigates murine acute graft-versus-host disease with retention of graft-versus-leukemia effects. |
| PubMedID- 21663506 | Imatinib mesylate in t-cell large granular lymphocyte leukemia associated with chronic graft-versus-host disease. |
| PubMedID- 25778886 | Objective: to explore the influence of relapse and survival by chronic graft versus host disease (cgvhd) in patients with acute myeloid leukemia (aml) after allogeneic hematopoietics stem cell transplantation (allo-hsct). |
| PubMedID- 24734223 | One drawback to aggressive immunomanipulation is the risk of causing gvhd in conjunction with the intended graft-vs.-leukemia (gvl) effect. |
Page: 1